Literature DB >> 569803

Audiologic manifestations in otitis media.

I Eliachar.   

Abstract

The pathologic processes that affect the middle ear transmission mechanisms in otitis media are dynamically variable and may cause different degrees of severity and changing pure tone configurations. By the same token, different disease conditions may yield similar audiometric curves. The air-bone gap is the chief indicator of middle ear abnormality but rarely provides a quantifying measure or a means of differential diagnosis. The clinician and audiologist must concern themselves singularly and together in achieving a correct diagnosis especially when there is concomitant neurosensory hearing loss. They must apply all the facilities at their disposal in order to correlate the otoscopic clinical findings with the magnitude and type of hearing loss.

Entities:  

Mesh:

Year:  1978        PMID: 569803

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  4 in total

1.  Clinical Profile of Tubotympanic CSOM and Its Management With Special Reference to Site and Size of Tympanic Membrane Perforation, Eustachian Tube Function and Three Flap Tympanoplasty.

Authors:  Nishant Kumar; Devashri Chilke; M P Puttewar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-07-06

2.  To Study the Association of the Size and Site of Tympanic Membrane Perforation with the Degree of Hearing Loss.

Authors:  Shubhangi Gupta; Rekha Harshvardhan; Sunil Samdani
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-02-07

3.  Parental suspicion of hearing loss in children with otitis media with effusion.

Authors:  Phoebe S Y Lo; Michael C F Tong; Eric M C Wong; C Andrew van Hasselt
Journal:  Eur J Pediatr       Date:  2006-07-22       Impact factor: 3.183

4.  Study the Effect of Tubotympanic Disease on Bone Conduction Threshold.

Authors:  Nitish Baisakhiya; Gurchand Singh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-06-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.